The Latest Breaking News from Pfizer

COVID-19 vaccines for kids under 5 may be available in the U.S. as early as March, but there are several hurdles still to clear

The Food and Drug Administration said Tuesday it will consider authorizing Pfizer’s COVID-19 vaccine for kids as young as 6 months, opening the door to immunizing some 23 million American children for whom vaccines haven’t yet been available.

France says it will start administering Pfizer’s coronavirus antiviral drug this week, the first pill for treating COVID-19 approved in the 27-nation EU

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) have 

FDA decision could come within weeks but big obstacles remain to getting all children inoculated

Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years. If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to…

A new study from the Center for Disease Control and Prevention confirms what Mayo Clinic and other experts have been saying: COVID-19 booster vaccinations improve protection against severe illness and hospitalization. The study examined people who had three doses of the Moderna or Pfizer COVID-19 vaccines, as well as whether…

Pfizer-BioNTech seeks US approval for under-5s Covid inoculation; Lithuania to scrap Covid pass on Saturday

So far, Pfizer’s vaccine has only been available to people at least five years old

Hospitalizations of children under 5 have reached their highest levels since the beginning of the pandemic.

Pfizer Inc. and partner BioNTech SE have begun submitting data to U.S. regulators for authorization of their COVID-19 vaccine in children 6 months to 4 years old, according to people familiar with the matter, hastening an effort to get shots to younger kids after the omicron wave caused pediatric infections…